News Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 04:00:08 2024-05-17 pm EDT			5-day change	1st Jan Change
44.01 ^USD	-0.23%		-2.07%	-14.23%

May. 16	Everlasting momentum
May. 16	Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis	May. 16	BU
Everlasting momentum	May. 16
Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma	May. 16	DJ
Bristol Myers Squibb : Transcript	May. 16	PU
Bristol-Myers Squibb Gets FDA Accelerated Approval for Breyanzi for Follicular Lymphoma	May. 16	MT
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma	May. 15	BU
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approves by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma	May. 15	CI
US FDA approves expanded use of Bristol's cancer cell therapy	May. 15	RE
Transcript : Bristol-Myers Squibb Company Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	May. 15
Transcript : Bristol-Myers Squibb Company Presents at Guggenheim Securities Radiopharmaceuticals Day, May-13-2024 11:00 AM	May. 13
Bristol-Myers Squibb Says Phase 3 Trial of Opdivo in Lung Cancer Fails to Meet Primary Endpoint	May. 10	MT
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint	May. 10	DJ
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial	May. 10	BU
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial	May. 10	CI
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says	May. 10	RE
Declaration of Voting Results by Bristol-Myers Squibb Company	May. 09	CI
Declaration of Voting Results by Bristol-Myers Squibb Company	May. 09	CI
India's Alembic Pharma posts higher Q4 profit on strong N.America sales	May. 09	RE
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	May. 07	MT
Bristol Myers Squibb to Participate in Upcoming Investor Conferences	May. 07	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST